Back
 IJCM  Vol.9 No.5 , May 2018
Effects of Community Mental Health Centers on Oxidative Stress in Patients with Schizophrenia
Abstract: Objective: The aim of our study was to evaluate of oxidative stress between the schizophrenic patients who regularly continued to Community Mental Health Centers (CMHC) and the patients who did not continue to CMHC. By this study, the effects of CMHC on oxidative stress between these two group of patients were assessed. Methods: Total number of 86 volunteers were enrolled in this study; 43 (27 males, 16 females) patients who regularly continued (average 2 years, at least 3 days a week) to CMHC and 43 (25 males, 18 females) patients who regularly did not continue to CMHC. Total antioxidative stress (TAS), total oxidative stress (TOS), oxidative stress index (OSI), paraoxanase (PON1), arylesterase (ARE) and total thiol (T.Thl) levels were measured with a novel automated method. Positive and Negative Syndrome Scale (PANSS) was used to assess the patients. Results: TOS, PANSS-Negative subscale and PANSS-Total subscale were found to be significantly higher in the group of patients who were not continuing to CMHC, than the group of patients who were continuing to CMHC. ARE and T.thl were found significantly lower in the group of patients who were not continuing to CMHC. There was a significant positive correlation between PANSS-Negative Subscale and TOS, OSI in the group of patients who were not continuing to CMHC. There was a positive correlation between PANSS-Negative Subscale and TOS in the group of patients who were continuing to CMHC. Conclusions: Oxidative stress and negative symptoms of schizophrenia in the group of patients who were continuing to CMHC were less than in the group of patients who were not continuing to CMHC. Thus, regular follow up at CMHC is very important in the treatment of schizophrenia patients.
Cite this paper: Kulaksizoglu, B. and Kulaksizoglu, S. (2018) Effects of Community Mental Health Centers on Oxidative Stress in Patients with Schizophrenia. International Journal of Clinical Medicine, 9, 423-431. doi: 10.4236/ijcm.2018.95036.
References

[1]   Angermeyer, M.C., Kühn, L. and Goldstein, J.M. (1990) Gender and the Course of Schizophrenia: Differences in Treated Outcomes. Schizophrenia Bulletin, 16, 293-307.
https://doi.org/10.1093/schbul/16.2.293

[2]   Salem, E.J. and Kring, M.A. (1998) The Role of Gender Differences in the Reduction of Etiologic Heterogeneity in Schizophrenia. Clinical Psychology Review, 18, 795-819.
https://doi.org/10.1016/S0272-7358(98)00008-7

[3]   Bassuk, E.L. and Gerson, S. (1978) Deinstitutionalization and Mental Health Services. Scientific American, 238, 46-53.
https://doi.org/10.1038/scientificamerican0278-46

[4]   Saglik Bakanligi, T.C. (2011) Toplum Ruh Sagligi Merkezleri Hakkinda Yönerge.

[5]   Saugstad, F.L. (1998) Social Class, Marriage, and Fertility in Schizophrenia. Schizophrenia Bulletin, 15, 9-43.

[6]   Rudyard, N. (1997) Stages in Realizing the International Diffusion of a Single Way of Working: The Clubhouse Model. New Directions for Mental Health Services, 74, 53-66.

[7]   Bitanihirwe, B.K. and Woo, T.U. (2011) Oxidative Stress in Schizophrenia: An Integrated Approach. Neuroscience and Biobehavioral Reviews, 35, 878-893.
https://doi.org/10.1016/j.neubiorev.2010.10.008

[8]   Erel, O. (2004) A Novel Automated Direct Measurement Method for Total Antioxidant Capacity Using a New Generation, More Stable ABTS Radical Cation. Clinical Biochemistry, 37, 277-285.
https://doi.org/10.1016/j.clinbiochem.2003.11.015

[9]   Erel, O. (2005) A New Automated Colorimetric Method for Measuring Total Oxidant Status. Clinical Biochemistry, 38, 1103-1111.
https://doi.org/10.1016/j.clinbiochem.2005.08.008

[10]   Haagen, L. and Brock, A.A. (1992) New Automated Method for Phenotyping Arylesterase (E.C.3.1.1.2.) Based upon Inhibition of Enzymatic Hydrolisis of 4-Nitrophenyl acetate. European Journal of Clinical Chemistry and Clinical Biochemistry, 30, 391-395.

[11]   Eckerson, H.W., Wyte, M.C. and La Du, B.N. (1983) The Human Serum Paraoxonase/Arylesterase Polymorphism. American Journal of Human Genetics, 35, 1126-1138.

[12]   Wlodek, L. (2002) Beneficial and Harmful Effects of Thiols. Polish Journal of Pharmacology, 54, 215-223.

[13]   Goswami, B., Tayal, D., Gupta, N. and Mallika, V. (2009) Paraoxonase: A Multifaceted Biomolecule. Clinica Chimica Acta, 410, 1-12.
https://doi.org/10.1016/j.cca.2009.09.025

[14]   Powers, S.K. and Hogan, M.C. (2016) Exercise and Oxidative Stress. The Journal of Physiology, 594, 5079-5080.
https://doi.org/10.1113/JP272255

[15]   First, M.B. and Pincus, H.A. (2002) The DSM-IV Text Revision: Rationale and Potential Impact on Clinical Practice. Psychiatric Services, 53, 288-292.
https://doi.org/10.1176/appi.ps.53.3.288

[16]   Kay, S.R., Fiszbein, A. and Opler, L.A. (1987) The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophrenia Bulletin, 13, 261-275.
https://doi.org/10.1093/schbul/13.2.261

[17]   Harma, M., Harma, M. and Erel, O. (2003) Increased Oxidative Stres in Patients with Hydatidiform Mole. Swiss Medical Weekly, 133, 563-566.

[18]   Ellman, G.L. (1959) Tissue Sulfhydryl Groups. Archives of Biochemistry and Biophysics, 82, 70-77.
https://doi.org/10.1016/0003-9861(59)90090-6

[19]   Hu, M.L. (1994) Measurement of Protein Thiol Groups and Glutathione in Plasma. Methods in Enzymology, 233, 380-385.
https://doi.org/10.1016/S0076-6879(94)33044-1

[20]   Kulaksizoglu, B. and Kulaksizoglu, S. (2016) Relationship between Neutrophil/Lymphocyte Ratio with Oxidative Stress and Psychopathology in Patients with Schizophrenia. Neuropsychiatric Disease and Treatment, 12, 1999.
https://doi.org/10.2147/NDT.S110484

[21]   Günes, M., Camkurt, M.A., Bulut, M., Demir, S., Ibiloglu, A.O., Kaya, M.C., et al. (2016) Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic Treatment. Clinical Psychopharmacology and Neuroscience, 14, 345-350.
https://doi.org/10.9758/cpn.2016.14.4.345

[22]   Pazvantoglu, O., Selek, S., Okay, I.T., Sengul, C., Karabekiroglu, K., Dilbaz, N., et al. (2009) Oxidative Mechanisms in Schizophrenia and Their Relationship with Illness Subtype and Symptom Profile. Psychiatry and Clinical Neurosciences, 63, 693-700.
https://doi.org/10.1111/j.1440-1819.2009.02015.x

[23]   Copoglu, U.S., Virit, O., Kokacya, M.H., Orkmez, M., Bulbul, F., Erbagci, A.B., et al. (2015) Increased Oxidative Stress and Oxidative DNA Damage in Non-Remission Schizophrenia Patients. Psychiatry Research, 229, 200-205.
https://doi.org/10.1016/j.psychres.2015.07.036

 
 
Top